Table 2 Analysis on clinical aspects and outcomes at the trauma center
Total (n = 2100) | Pre-COVID-19 (n = 1317) | COVID-19 (n = 783) | p-value | ||
|---|---|---|---|---|---|
Vital signa | |||||
SBP (mmHg) | 136 [115–156] | 136 [116–156] | 135 [113–155] | 0.352 | |
DBP (mmHg) | 80 [67–90] | 79 [66–90] | 80 [68–90] | 0.250 | |
PR (/min) | 85 [73–99] | 86 [73–99] | 85 [74–98] | 0.943 | |
BT (oC) | 36.8 [36.4–37.1] | 36.8 (36.4–37.1] | 36.9 [36.5–37.2] | 0.677 | |
RR (/min) | 18 [16–18] | 18 [16–18] | 18 [18–20] | 0.074 | |
Saturation (%) | 98 [96–99] | 98 [96–98] | 98 [96–99] | 0.574 | |
SI | 0.61 [0.49–0.76] | 0.61 [0.49–0.76] | 0.61 [0.50–0.75] | 0.894 | |
Cardiac arrest before arrival | 0.509 | ||||
38 (1.8) | 25 (1.9) | 13 (1.7) | |||
GCSa | 0.663 | ||||
15 [15–15] | 15 [15–15] | 15 [15–15] | |||
TTA | < 0.001 | ||||
Yes | 532 (25.3) | 293 (22.2) | 239 (30.5) | ||
No | 1568 (74.7) | 1024 (77.8) | 544 (69.5) | ||
ISSa | 0.546 | ||||
9 [4–14] | 9 [4–14] | 9 [4–14] | |||
ISS > 15 | 508 (24.2) | 314 (23.8) | 194 (24.8) | 0.119 | |
Blood product (pRBC) transfusion | |||||
Required in first 4 h | 263 (12.5) | 160 (12.1) | 103 (13.2) | 0.501 | |
Amount(pint)b | |||||
<4 h | 0.66 ± 2.78 | 0.66 ± 2.83 | 0.65 ± 2.69 | ||
4-24 h | 1.18 ± 5.01 | 1.23 ± 5.16 | 1.09 ± 4.75 | ||
TC stay (m)a | 0.940 | ||||
288 [134–603] | 282 [130–639] | 306 [142–564] | |||
Direct OR/IR | 0.350 | ||||
279 (13.3) | 182 (13.8) | 97 (12.4) | |||
ICU care | |||||
No of patient | 695 (33.1) | 432 (32.8) | 263 (33.6) | 0.711 | |
LOS (h)b | 54.5 ± 151.9 | 55.0 ± 159.3 | 53.7 ± 138.6 | 0.853 | |
2nd transfer | 0.426 | ||||
384 (18.3) | 234 (17.8) | 150 (19.2) | |||
Mortality | |||||
Total | 102 (4.9) | 67 (5.1) | 35 (4.5) | 0.525 | |
Death < 24 h† | 45 (2.1) | 26 (2.0) | 19 (2.4) | 0.489 | |
< 48 h† | 51 (2.4) | 31 (2.4) | 20 (2.6) | 0.773 | |
< 7d† | 70 (3.3) | 43 (3.3) | 27 (3.4) | 0.821 | |
< 30d† | 88 (4.2) | 55 (4.2) | 33 (4.2) | 0.966 |